Bangdong Gong
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome (NCT06967038) | Bangdong Gong | 2025-02-28 |
Track Bangdong Gong automatically
Every clearance here is in the API, with alerts when new ones post.